Pharmacy fingertip Testing at 374 MDSS at Yokota Air Base Japan
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DEFENSE HEALTH AGENCY HCD WEST
Contract Value
Not provided
Codes & Classification
Solicitation Number
HT941026Q2067
NAICS
541380 - Testing Laboratories and Services
Classification Code
Q301
Additional Details
Documents5
The Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division-West (HCD-W), has issued a combined synopsis/solicitation (Solicitation Number: HT941026Q2067) seeking qualified sources to provide pharmacy fingertip testing services at the 374th Medical Support Squadron (MDSS), Yokota Air Base, Japan. This procurement is conducted as a Request for Quote (RFQ) for commercial items in accordance with Federal Acquisition Regulation (FAR) Part 12, and constitutes both the synopsis and the solicitation; no separate written solicitation will be issued.
The primary objective of this procurement is to secure non-personal services for pharmacy fingertip testing in support of the 374th Medical Group’s sterile intravenous (IV) compounding operations. The required services must ensure compliance with The Joint Commission (TJC) and United States Pharmacopeia (USP) 797 standards, which are critical for maintaining the safety and quality of sterile compounding practices. The contractor will be expected to perform all services in accordance with the Performance Work Statement (PWS) and any additional attachments provided with the solicitation.
The period of performance for this contract includes a base year with four additional option years, supporting the long-term operational needs of the medical group at Yokota Air Base. The place of performance is exclusively at Yokota, Japan.
This opportunity is classified under NAICS code 541380 (Testing Laboratories and Services), with the corresponding Product Service Code Q301. The procurement is unrestricted, inviting full and open competition; there are no set-aside requirements for small businesses or other socioeconomic categories.
Interested contractors should note that this is a non-personal services contract, meaning that contractor personnel will not be subject to supervision or control by government employees beyond that necessary to ensure contract compliance. All work must adhere to the standards and requirements outlined in the PWS and referenced attachments, which are accessible via the solicitation’s listing on SAM.gov.
The solicitation incorporates standard provisions and clauses by reference, which can be reviewed in full at www.acquisition.gov. Contractors are encouraged to review all attachments, including the PWS and any Q&A documents, to ensure a comprehensive understanding of the requirements.
The contracting entity for this procurement is the Defense Health Agency HCD West, a federal office under the Department of Defense. The primary point of contact for this solicitation is Raphael Badagbor ([email protected]), with Marcela Cervantes ([email protected]) listed as the secondary contact.
The solicitation is currently active, with a response deadline of August 26, 2026, at 18:08 local time. Interested parties should submit their quotes in accordance with the instructions provided in the solicitation documents. For further details and to access all attachments, contractors should refer to the official notice on SAM.gov at https://sam.gov/opp/e2154c0d59d9490787e3119808c6320f/view.
This opportunity is well-suited for contractors with expertise in laboratory testing services, particularly those experienced in supporting healthcare environments and familiar with TJC and USP 797 compliance requirements for sterile compounding. The long-term nature of the contract and the critical role of these services in supporting military healthcare operations make this a significant opportunity for qualified providers.